Cidlowski J A, Bellingham D L, Powell-Oliver F E, Lubahn D B, Sar M
Department of Physiology, University of North Carolina, Chapel Hill 27599.
Mol Endocrinol. 1990 Oct;4(10):1427-37. doi: 10.1210/mend-4-10-1427.
We have synthesized two peptides that correspond to unique regions of the amino-terminus of the human glucocorticoid receptor (GR). Peptides representing amino acids 245-259 and 346-367 (designated 59 and 57, respectively) were chosen on the basis of hydrophobicity/hydrophilicity ratios as well as overall proline content. These peptides were then used as antigens to produce epitope-specific antibodies that recognize and interact with human GR in a variety of physical states. Antiserum directed against each peptide recognizes denatured, [3H] dexamethasone mesylate-labeled GR as well as unliganded receptor on Western blots. In contrast to other antipeptide GR antibodies, these antibodies recognize and form stable complexes with unactivated and molybdate-stabilized forms of the GR, indicating that neither epitope is occluded when the receptor exists in an oligomeric state. Activated, 4S DNA-binding forms of the receptor are also recognized by both antibodies. The interaction of antibodies 59 and 57 with human GR in various states is highly specific based on the observation that preincubation of either antiserum with the appropriate peptide completely precludes the recognition of receptor by antibody. Titration analysis of antisera reveals that an increase in the antibody concentration cause discrete increases in the sedimentation coefficient of GR on sucrose gradients. These shifts occur under high salt conditions and are consistent with the formation of multiple stable antibody-receptor complexes. Interestingly, neither antibody interferes with the ability of the GR to be activated into a DNA-binding form or with the ability of the activated GR to interact with DNA cellulose. Consistent with these observations, both antibodies recognize and form stable complexes with GR when the receptor is associated with DNA fragments that contain specific glucocorticoid-responsive elements. Thus, both antibodies appear to recognize all known forms of the human GR protein. Using immunohistochemical techniques to visualize GR in HeLa S3 cells as well as in Chinese hamster ovary cells that stably express transfected human GR, a cytoplasmic location for receptor is observed in the absence of ligand. In contrast, immunoreactive GR is predominantly nuclear after hormone treatment, further supporting a role for nuclear translocation in GR function.
我们合成了两种与人类糖皮质激素受体(GR)氨基末端独特区域相对应的肽。根据疏水性/亲水性比率以及脯氨酸的总体含量,选择了代表氨基酸245 - 259和346 - 367的肽(分别命名为59和57)。然后将这些肽用作抗原,以产生能在多种物理状态下识别并与人GR相互作用的表位特异性抗体。针对每种肽的抗血清在蛋白质印迹中能识别变性的、[³H]甲磺酸地塞米松标记的GR以及未结合配体的受体。与其他抗肽GR抗体不同,这些抗体能识别未活化的和经钼酸盐稳定化的GR形式并与之形成稳定复合物,这表明当受体以寡聚体状态存在时,两个表位均未被遮蔽。两种抗体也能识别活化的、4S DNA结合形式的受体。基于以下观察结果,即任一抗血清与相应肽预孵育会完全阻止抗体对受体的识别,抗体59和57与不同状态下的人GR的相互作用具有高度特异性。抗血清的滴定分析表明,抗体浓度的增加会导致GR在蔗糖梯度中的沉降系数离散性增加。这些变化在高盐条件下发生,并且与形成多个稳定的抗体 - 受体复合物一致。有趣的是,两种抗体均不干扰GR被激活成DNA结合形式的能力,也不干扰活化的GR与DNA纤维素相互作用的能力。与这些观察结果一致,当受体与含有特定糖皮质激素反应元件的DNA片段结合时,两种抗体均能识别并与GR形成稳定复合物。因此,两种抗体似乎都能识别已知的人GR蛋白的所有形式。使用免疫组织化学技术在HeLa S3细胞以及稳定表达转染人GR的中国仓鼠卵巢细胞中可视化GR,在无配体时观察到受体位于细胞质中。相反,激素处理后,免疫反应性GR主要位于细胞核中,进一步支持了核转位在GR功能中的作用。